Depression of liver metabolism and induction of cytokine release by diphtheria and tetanus toxoids and pertussis vaccines: role of Bordetella pertussis cells in toxicity

A 24-h pretreatment of mice with diphtheria and tetanus toxoids and whole-cell pertussis vaccines depressed liver cytochrome P-450 and therefore prolonged hexobarbital-induced sleeping time in mice. The depression of liver drug metabolism by a cellular vaccine containing a mutated pertussis toxin was less marked than that induced by the wild-type vaccines, indicating that the mutated vaccine might have lower toxicity in this regard. The wild-type vaccines decreased microsomal P-450 levels by 50%, while the mutated whole-cell vaccine had a less marked effect (a decrease of 30%), paralleling the results obtained in sleeping time experiments. Furthermore, an acellular mutated vaccine did not affect liver drug metabolism, indicating a role of the whole bacterial cell in this side effect. All the cellular vaccines studied induced high serum interleukin-6 levels; on the other hand, the acellular mutated vaccine induced very low interleukin-6 levels, indicating that the whole bacterial cell is also important for interleukin-6 induction. All vaccines studied were very poor tumor necrosis factor inducers.

[1]  P. Snoy,et al.  Role of endotoxin in alterations of hepatic drug metabolism by diphtheria and tetanus toxoids and pertussis vaccine adsorbed , 1992, Infection and immunity.

[2]  L. Nencioni,et al.  Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule , 1992, Infection and immunity.

[3]  W. Habig,et al.  Vaccine-induced alterations in hepatic drug metabolism. , 1991, Vaccine.

[4]  A. Mantovani,et al.  IL-1 stimulates IL-6 production in endothelial cells. , 1989, Journal of immunology.

[5]  P. Ghezzi,et al.  Recombinant tumor necrosis factor reduces hepatic drug metabolism in vivo in the rat. , 1988, Journal of biological response modifiers.

[6]  P. Ghezzi,et al.  Role of interleukin-1 in the depression of liver drug metabolism by endotoxin , 1986, Infection and immunity.

[7]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[8]  P. Ghezzi,et al.  Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice. , 1986, Biochemical and biophysical research communications.

[9]  P. Ghezzi,et al.  Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice. , 1985, Cancer research.

[10]  D. Goeddel,et al.  Human tumor necrosis factor. Production, purification, and characterization. , 1985, The Journal of biological chemistry.

[11]  M. Huang,et al.  Effects of three recombinant human leukocyte interferons on drug metabolism in mice. , 1982, Drug metabolism and disposition: the biological fate of chemicals.

[12]  C. McClain,et al.  Depression of aminopyrine metabolism by influenza vaccination. , 1981, The New England journal of medicine.

[13]  K. Renton,et al.  EFFECTS OF INTERFERON‐INDUCING AGENTS ON HEPATIC CYTOCHROME P‐450 DRUG METABOLIZING SYSTEMS * , 1980, Annals of the New York Academy of Sciences.

[14]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[15]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[16]  R. Rappuoli,et al.  Progress towards the development of new vaccines against whooping cough. , 1992, Vaccine.